Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-07-09

FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

The FDA approved Ascend Laboratories' supplemental application for amlodipine besylate, confirming the approval of the ANDA supplement for this generic product.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine besylate (amlodipine besylate)

Snippet

SUPPL AP for AMLODIPINE BESYLATE (AMLODIPINE BESYLATE)